Skip to content

Biomarkers in the blood and skeletal muscle for the improvement of viral myocarditis diagnostics

Biomarkers in the blood and skeletal muscle for the improvement of viral myocarditis diagnostics - Diagnostic biomarkers in viral myocarditis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON47465
Enrollment
200
Registered
2013-06-07
Start date
2013-12-12
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

viral infection of the heart viral myocarditis

Interventions

None listed

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: In the viral myocarditis group patients will be included when they are mentally competent and when they present with suspected viral myocarditis (show flu-like symptoms combined with acute loss of heart function) and comply to the ESC/ACC position statement for endomyocardial biopsy. In the AMI group (controls) patients will be included when they are mentally competent and present with an acute myocardial infarction. Because viral myocarditis can mimic AMI, we will also include patients who present with infarct-like complaints, but show non-occluded epicardial coronary arteries with coronary angiography. Based on subsequent MRI analyses, these patients will later be subdivided into the AMI group (in case of myocardial infarction with non-occluded coronary arteries (MINOCA)) or the viral myocarditis group.

Exclusion criteria

Exclusion criteria: In the viral myocarditis group the main exclusion criteria are: acute myocardial infarction, prednisolon use or fear of MRI. In the AMI group the main exclusion criteria are to suffer from a viral infection (including HIV). In both groups prednisolon use and mental incompetence is an exclusion cirteria.

Design outcomes

Primary

MeasureTime frame
De primary study parameters are the differences in biomarker profile (in heart, blood and skeletal muscle) between viral myocarditis (and the potential subgroups within this group) and acute myocardial infarction patients, as well as the determination of virus type and titer in relation to the pathophysiology of these (sub)groups.

Secondary

MeasureTime frame
N.A.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)